1) mixed bone marrow transplantation
混合骨髓移植
1.
In this paper, a model of three allogeneic mixed bone marrow transplantation of mice (BALB/c, H 2 d; C57BL/6, H 2 b; and CBA/N, H 2 k) was established and whether or not prolongation of the survival time in recipient mice was observed.
本研究目的为建立 3种异基因小鼠 (BALB/c ,H 2 d;C5 7BL/ 6 ,H 2 b 和CBA/N ,H 2 k)混合骨髓移植模型(A +B +C→A) ,观察此模型能否延长骨髓移植后受体鼠的存活时间。
2.
Part I Experimental study of G-CSF moderating GVHD after Mixed bone marrow transplantationMethods: Female BALB/c mice and neonatal BALB/c mice were recipients and male (BALB/cxC57BL/6) Fl (BCFi) mice were donor mice.
第一部分G-CSF减轻混合骨髓移植后GVHD的实验研究 方法 受鼠为雌性BALB／c小鼠及出生48～72h的BALB／c新生小鼠，供鼠为雄性(BALB／c×C_(57)BL／6)F_1(BCF_1)小鼠。
2) Bone marrow transplantation
骨髓移植
1.
Application of multiplex amplification of STRs for monitoring survival of engraftment after bone marrow transplantation;
用荧光标记短串连重复复合扩增技术监测骨髓移植存活
2.
Intestine necrosis is the primary cause of death in SCID mice with heterogeneous bone marrow transplantation;
肠坏死是异种骨髓移植后SCID鼠发生急性排斥反应死亡的主要原因
3.
Effects of the splenocytes in murine mixed bone marrow transplantation;
小鼠脾细胞在混合骨髓移植中的作用
3) Marrow transplantation
骨髓移植
1.
CD_(25)monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia;
CD_(25)抗体预防移植物抗宿主病在儿童白血病半匹配骨髓移植中的应用
2.
Nursing of intravenous ducts under collarbone in patients receiving marrow transplantation;
骨髓移植病人留置锁骨下静脉导管的护理
3.
To explore feasibility and efficacy of unrelated HLA matched donor marrow transplantation in treatment of myelodysplastic syndrome,one case (male,31 years old) of myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia (MDS-RCMD) has been received unrelated HLA-matched donor transplantation.
为了探讨非亲缘HLA相合供者骨髓移植 (UD BMT)治疗骨髓增生异常综合征 (MDS)的可行治疗方案和疗效 ,采用HLA配型相合的非亲缘骨髓移植治疗 1例骨髓增生异常综合征 难治性血细胞减少伴多系病态造血(MDS RCMD)男性患者 ,31岁。
4) bone marrow transplant
骨髓移植
1.
Efficacy of splenocytes in inducing stable long-term chimerism in murine mixed haploidentical MHC matched bone marrow transplant model;
小鼠混合骨髓移植中脾细胞诱导持久稳定嵌合体的作用
2.
Objective To study the liver function of the SD rats which were ill with hepatocirrhosis after bone marrow transplant.
目的研究骨髓移植后,患肝硬化SD大鼠的肝功能的缓解情况。
3.
Objective Use a novel fluorogence quantitative PCR assay to monitor active human cytomegalovirus(HCMV) infection in the bone marrow transplant recipients.
目的用定量PCR方法监测骨髓移植患者中人巨细胞病毒 (humancytomegalovirus,HCMV)活动性感染。
5) BMT
骨髓移植
1.
In order to evaluate the diagnostic value of fibrotic bronchoscopy(FB) in the pulmonary infiltration following bone marrow transplantation(BMT),18 patients with pulmonary complications after BMT from November 2003 to March 2006 were performed with FB.
为了评估骨髓移植术后肺部弥漫性病变诊断中纤维支气管镜检(fibroptic bronchoscopy,FB)的应用价值,对2003年11月-2006年3月间18例骨髓移植术后出现肺部弥漫性病变、短期经验治疗效果欠佳的患者行FB,并做支气管肺泡灌洗(BAL)及刷检涂片,其中3例条件许可者加支气管镜肺活检(TBLB)。
2.
FasL gene-modified dendritic cells alleviating GVHD Allogeneic bone marrow transplantation (alloBMT) has revolutionized thetreatment of hematopoietic malignancies, inherited hematopoietic disorders, andaplastic anemia.
FasL 基因修饰的树突状细胞抑制 GVHD 反应和机理 同种异基因骨髓移植(allo-gene Bone Marrow Transplantation,alloBMT)是治疗恶性血液疾病、血液系统遗传性疾病、再生障碍性贫血等疾病的一种有效方法,不幸的是移植物抗宿主病(Graft Versus Host Disease, GVHD)仍然是其主要的并发症,并且具有高发病率、高死亡率,严重限制了alloBMT的应用和发展。
3.
Objective:To study the effects of immunotherapy with synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides (CpG-ODNs) and GM-CSF (CpG+GM-CSF) in the erythroleukemia-bearing mice after syngeneic bone marrow transplantation (syn-BMT).
目的 荷红白血病(EL9611)小鼠同基因骨髓移植(syn-BMT)后，经采用非甲基化胞嘧啶鸟嘌呤二核苷酸(CpG-ODNs)联合GM-CSF和／或肿瘤疫苗进行免疫治疗，观察其诱导syn-BMT后抗白血病特异性免疫能力的效应，并初步探讨其免疫机理。
6) marrow transplant
骨髓移植
1.
In fact,as early as in 2005 we pointed out the possibility of marrow transplantation for the treatment of AIDS in an article in the Journal of Nanhua University(Medical Edition).
本研究室曾在1998年讨论了CCR5用于艾滋病防治的可能性,随后提出了骨髓移植治疗艾滋病的观点。
补充资料：骨髓移植
| 骨髓移植 bone marrow transplantation 将正常骨髓由静脉输入患者体内，以取代病变骨髓的治疗方法。简称BMT。骨髓中有大量多能造血干细胞，具有自我复制和分化两种基本功能，在患者体内植活后，患者的造血功能和免疫功能即得以重建。 类型 根据骨髓的来源不同，BMT有3种类型：①同种异基因BMT。指人类不同个体间的移植，目前大多数BMT都指此而言，供者和受者的人类白细胞抗原(HLA）配型相合是移植成功的必要条件，亲兄弟姐妹间相合的机率是25％，无关供者相匹配的机率很少。②同基因BMT。即同卵双生子女间的BMT，效果最好。③自体BMT。即用自身的骨髓，不需供髓者，此法简便，易于推广，可广泛用于独生子女。 适应症 受者的年龄一般应小于45岁，自体BMA可高至55岁，应无重大内、外科疾病，具体适用于如下两类疾病，第一类是恶性疾病，包括：①完全缓解后的急性白血病，BMT后的5年生存率可达70％。②慢性粒细胞白血病的慢性期，80％可长期缓解或根治。③其他如难治性恶性淋巴瘤、多发性骨髓瘤、小细胞肺癌等常采用自体BMT，疗效显著。第二类是非恶性疾病如再生障碍性贫血和重症联合免疫缺陷病等。今后随着供髓者的选择、感染和移植物抗宿主病防治的解决，BMT必将被推广和显示巨大生命力。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条